Taken together, our findings suggested that GEN1 may promote ovarian cancer cell proliferation, invasion and migration by influencing the expression of immune inhibitory factors, thereby presumably elevating the proportion of PMN-MDSCs and constructing an immunosuppressive tumor microenvironment. Here, GEN1 is linked to ovarian carcinoma.